INHIBITING MIR-10A OVERCOMES CYTARABINE-RESISTANCE IN ACUTE MYELOID LEUKAEMIA

被引：0
|
作者：
Vu, T. T. [1 ]
Wang, K. [1 ]
Stoelzel, F. [2 ]
Ehninger, G. [2 ]
Molloy, T. [1 ]
Ma, D. [1 ]
机构：
[1] St Vincents Hosp, Haematol, Sydney, NSW, Australia
[2] Univ Hosp Carl Gustav Carus, Med Clin & Policlin 1, Dresden, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E880
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [21] Multidrug resistance in acute myeloid leukaemia
    Sonneveld, P
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 185 - 203
  • [22] Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence
    Ren, Xiyang
    Yan, Haotian
    Zhou, Mei
    Wu, Fan
    Zhang, Qing
    Ding, Yangyang
    Li, Qian
    Wang, Huiping
    Xu, Caixian
    Wang, Jiyu
    Li, Cong
    Zhang, Wanqiu
    Liu, Linlin
    Chen, Ruotong
    Dong, Yi
    Dai, Wenjie
    Zhai, Zhimin
    Tao, Qianshan
    BLOOD, 2024, 144 : 2754 - 2754
  • [23] Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
    Degwert, Nicole
    Latuske, Emily
    Vohwinkel, Gabi
    Stamm, Hauke
    Klokow, Marianne
    Bokemeyer, Carsten
    Fiedler, Walter
    Wellbrock, Jasmin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (03) : 239 - 244
  • [24] Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
    Levin, May
    Stark, Michal
    Berman, Bluma
    Assaraf, Yehuda G.
    CELL DEATH & DISEASE, 2019, 10 (6)
  • [25] Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
    May Levin
    Michal Stark
    Bluma Berman
    Yehuda G. Assaraf
    Cell Death & Disease, 10
  • [26] Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia
    Zhang, Ting-juan
    Guo, Hong
    Zhou, Jing-dong
    Li, Xi-xi
    Zhang, Wei
    Ma, Ji-chun
    Wen, Xiang-mei
    Yao, Xin-yu
    Lin, Jiang
    Qian, Jun
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (01) : 169 - 173
  • [27] Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
    Jost, Felix
    Schalk, Enrico
    Rinke, Kristine
    Fischer, Thomas
    Sager, Sebastian
    PLOS ONE, 2019, 14 (07):
  • [28] Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia
    Longu, Francesco
    Fozza, Claudio
    Dessi, Laura
    Longinotti, Maurizio
    Bonfigli, Silvana
    Careddu, Maria Grazia
    Coppola, Lorenzo
    Giannico, Domenica Barbara
    Nieddu, Rosa Maria
    Podda, Luigi
    Pardini, Simonetta
    Dore, Fausto
    Dore, Simone
    Sotgiu, Giovanni
    ACTA HAEMATOLOGICA, 2017, 137 (01) : 15 - +
  • [29] LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells
    Yuan, Zhongtao
    Wang, Wei
    HEMATOLOGY, 2020, 25 (01) : 160 - 164
  • [30] Homoharringtonine Overcomes Drug Resistance and Synergises with Venetoclax in Acute Myeloid Leukemia Via Inhibiting Protein Synthesis
    Kwok, Tsz Ho
    Wong, Kelvin King Wai
    Lam, Wing
    Dang, Chee Chean
    Zeng, Xiaoyuan
    Leung, Wing Yan
    Ng, Timothy Chi Chun
    Leung, Anskar
    Man, Cheuk Him
    BLOOD, 2022, 140 : 11540 - 11540
12345